Pfizer Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	7,676	5,513	6,239	6,126	4,976
Depreciation & Amortization	586.1	601	1,033	1,128	1,072
Other Amortization	21.8	21.8	21.8	21.8	21.8
Loss (Gain) From Sale of Assets	-1,713	30.5	-2,561	-15.8	-0.8
Stock-Based Compensation	136.6	144.5	127	117.7	105.6
Provision & Write-off of Bad Debts	13.3	7.8	17.7	45.7	-5.2
Other Operating Activities	-694.8	-1,299	-984	-1,203	-979.5
Change in Accounts Receivable	-68.2	-365.1	-102	-183.5	219.4
Change in Inventory	-422.2	-160	218.5	-138.6	-44.6
Change in Accounts Payable	-153.1	-502	-381.1	-111.9	-1,409
Change in Other Net Operating Assets	1,211	-1,434	-80.3	873.4	316.7
Operating Cash Flow	6,598	2,568	3,557	6,671	4,273
Operating Cash Flow Growth	156.87%	-27.79%	-46.68%	56.10%	32.23%
Capital Expenditures	-281.5	-189.3	-649.8	-153.1	-177
Sale of Property, Plant & Equipment	2	0.2	12.2	20.6	0.8
Divestitures	-	-	1,805	-	-
Sale (Purchase) of Real Estate	1,517	528.8	-	-	-
Investment in Securities	-3,543	-1,093	-2,293	-6,125	-5,020
Other Investing Activities	1,592	1,290	765.2	507.3	507.7
Investing Cash Flow	-713.4	537	-360.5	-5,750	-4,688
Long-Term Debt Repaid	-373.1	-410.5	-352	-98.9	-490.9
Net Debt Issued (Repaid)	-373.1	-410.5	-352	-98.9	-490.9
Common Dividends Paid	-1,603	-1,834	-1,698	-1,597	-998.11
Other Financing Activities	-77.8	-106.6	-133.8	-108.8	-26.3
Financing Cash Flow	-2,053	-2,351	-3,458	-1,805	-15,711
Net Cash Flow	3,831	754	-261.6	-884.5	-16,126
Free Cash Flow	6,316	2,379	2,907	6,518	4,096
Free Cash Flow Growth	165.48%	-18.16%	-55.40%	59.11%	43.84%
Free Cash Flow Margin	27.68%	10.85%	11.99%	24.96%	18.28%
Free Cash Flow Per Share	138.06	52.01	63.54	142.46	89.54
Cash Interest Paid	77.8	106.6	133.8	108.8	26.3
Cash Income Tax Paid	1,562	1,538	3,026	2,259	2,041
Levered Free Cash Flow	5,012	2,334	3,393	7,385	3,932
Unlevered Free Cash Flow	5,065	2,430	3,476	7,451	4,027
Change in Working Capital	567.9	-2,461	-344.9	439.4	-917.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.